Cara Therapeutics (Germany) Price History
| 69C Stock | EUR 4.84 0.00 0.00% |
If you're considering investing in Cara Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cara Therapeutics stands at 4.84, as last reported on the 20th of March, with the highest price reaching 4.84 and the lowest price hitting 4.84 during the day. Cara Therapeutics appears to be unstable, given 3 months investment horizon. Cara Therapeutics secures Sharpe Ratio (or Efficiency) of 0.19, which signifies that the company had a 0.19 % return per unit of risk over the last 3 months. By analyzing Cara Therapeutics' technical indicators, you can evaluate if the expected return of 0.82% is justified by implied risk. Please makes use of Cara Therapeutics' Mean Deviation of 3.25, downside deviation of 5.11, and Risk Adjusted Performance of 0.115 to double-check if our risk estimates are consistent with your expectations.
Cara Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cara |
Sharpe Ratio = 0.1897
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 69C | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.33 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.82 actual daily | 16 84% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average Cara Therapeutics is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cara Therapeutics by adding it to a well-diversified portfolio.
Cara Therapeutics Stock Price History Chart
There are several ways to analyze Cara Stock price data. The simplest method is using a basic Cara candlestick price chart, which shows Cara Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Cara Stock Price History Data
The price series of Cara Therapeutics for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 2.66 with a coefficient of variation of 22.91. The prices are distributed with arithmetic mean of 4.19. The median price for the last 90 days is 4.84. The company had 12:1 stock split on 19th of December 2024.| Open | High | Low | Close | Volume | ||
03/20/2025 | 4.84 | 4.84 | 4.84 | 4.84 | ||
| 02/28/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/27/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/26/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/25/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/24/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/21/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/20/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/19/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/18/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/17/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/14/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/13/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/12/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/11/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/10/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/07/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/06/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/05/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/04/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 02/03/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/31/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/30/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/29/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/28/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/27/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/24/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/23/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/22/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/21/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/20/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/17/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/16/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/15/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/14/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/13/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/10/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/09/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/08/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/07/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/06/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/03/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 01/02/2025 | 4.84 | 4.84 | 4.84 | 4.84 | 1.00 | |
| 12/30/2024 | 4.84 | 4.84 | 4.84 | 4.84 | 35.00 | |
| 12/27/2024 | 4.69 | 4.94 | 4.69 | 4.94 | 1.00 | |
| 12/23/2024 | 4.31 | 4.31 | 4.31 | 4.31 | 1.00 | |
| 12/20/2024 | 3.42 | 3.42 | 3.42 | 3.42 | 1.00 | |
| 12/19/2024 | 2.28 | 2.28 | 2.28 | 2.28 | 1.00 | |
| 12/18/2024 | 2.38 | 2.38 | 2.38 | 2.38 | 1.00 | |
| 12/17/2024 | 2.46 | 2.46 | 2.46 | 2.46 | 41.00 | |
| 12/16/2024 | 2.51 | 2.51 | 2.51 | 2.51 | 1.00 | |
| 12/13/2024 | 2.52 | 2.52 | 2.52 | 2.52 | 1.00 | |
| 12/12/2024 | 2.56 | 2.82 | 2.56 | 2.82 | 1.00 | |
| 12/11/2024 | 2.63 | 2.63 | 2.63 | 2.63 | 1.00 | |
| 12/10/2024 | 2.94 | 2.94 | 2.94 | 2.94 | 1.00 | |
| 12/09/2024 | 2.70 | 2.70 | 2.70 | 2.70 | 1.00 | |
| 12/06/2024 | 2.77 | 2.77 | 2.77 | 2.77 | 1.00 | |
| 12/05/2024 | 2.81 | 2.81 | 2.81 | 2.81 | 1.00 | |
| 12/04/2024 | 2.83 | 2.83 | 2.83 | 2.83 | 1.00 | |
| 12/03/2024 | 2.92 | 2.92 | 2.92 | 2.92 | 1.00 | |
| 12/02/2024 | 2.99 | 2.99 | 2.99 | 2.99 | 1.00 |
About Cara Therapeutics Stock history
Cara Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cara is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cara Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cara Therapeutics stock prices may prove useful in developing a viable investing in Cara Therapeutics
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. Cara Therapeutics, Inc. was founded in 2004 and is headquartered in Stamford, Connecticut. Cara Therapeutics operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 55 people.
Cara Therapeutics Stock Technical Analysis
Cara Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Cara Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cara Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cara Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cara to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.115 | |||
| Jensen Alpha | 0.8278 | |||
| Total Risk Alpha | 1.76 | |||
| Sortino Ratio | 0.1981 | |||
| Treynor Ratio | (1.01) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Cara Stock analysis
When running Cara Therapeutics' price analysis, check to measure Cara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cara Therapeutics is operating at the current time. Most of Cara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cara Therapeutics' price. Additionally, you may evaluate how the addition of Cara Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |